<DOC>
	<DOCNO>NCT00402207</DOCNO>
	<brief_summary>Background Chronic inflammation peripheral airway play important role pathophysiology asthma . Extrafine hydrofluoroalkane ( HFA ) beclometasone distinguish ICS fine aerosol characteristic . As result , great extent deposition extrafine HFA-beclometasone peripheral airway . Therefore , extrafine HFA-beclometasone may extra anti-inflammatory effect child asthma . Aim To analyse potential extra anti-inflammatory effect extrafine HFA-beclometasone compare HFA-flucticasone child asthma mean alveolar nitric oxide ( NO ) concentration bronchial NO flux , inflammatory marker exhale breath condensate ( EBC ) , conventional parameter . Method In cross-over study design 6 month , 33 child , age 6-12 year , doctor diagnose mild persistent asthma , treat extrafine HFA-beclometasone inhale autohaler HFA-flucticasone inhaled discus . Primary outcome parameter study ; alveolar NO concentration bronchial NO flux . Secondary outcome parameter inflammatory marker EBC , lung function parameter , symptom , presence duration exacerbation adverse effect . All parameter record baseline treatment period .</brief_summary>
	<brief_title>The Anti-Inflammatory Effect Extrafine HFA-Beclometasone Versus HFA-Fluticasone , Means Inflammometry</brief_title>
	<detailed_description />
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>age 6.5 12 year child mildpersistent asthma treatment inhaled corticosteroid ( ≤ 500 μg HFAFlucticasone , ≤ 800 μg Budesonide , ≤ 800 μg HFABeclometasone , daily ) allow , need use entire study period ; short / longacting β2agonists leukotrien receptor antagonist antihistamines Instability asthma past 3 month Presence disease may intervene result study Active smoke Mental retardation Inability perform measurement properly</criteria>
	<gender>All</gender>
	<minimum_age>78 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>asthma</keyword>
	<keyword>non-invasive inflammometry</keyword>
	<keyword>exhale nitric oxide</keyword>
	<keyword>exhale breath condensate</keyword>
	<keyword>paediatric</keyword>
	<keyword>extrafine HFA-beclomethasone</keyword>
	<keyword>HFA-fluticasone</keyword>
</DOC>